Parkside Financial Bank & Trust’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.2K | Sell |
2,819
-18
| -0.6% | -$391 | 0.01% | 826 |
|
|
2025
Q1 | $68.8K | Buy |
2,837
+182
| +7% | +$4.41K | 0.01% | 717 |
|
|
2024
Q4 | $55.4K | Hold |
2,655
| – | – | 0.01% | 765 |
|
|
2024
Q3 | $52.8K | Buy |
2,655
+418
| +19% | +$8.31K | 0.01% | 761 |
|
|
2024
Q2 | $34.7K | Sell |
2,237
-438
| -16% | -$6.79K | 0.01% | 869 |
|
|
2024
Q1 | $42.6K | Buy |
2,675
+812
| +44% | +$12.9K | 0.01% | 785 |
|
|
2023
Q4 | $31.3K | Buy |
+1,863
| New | +$31.3K | 0.01% | 841 |
|
|
2023
Q2 | – | Sell |
-132
| Closed | -$2.19K | – | 2029 |
|
|
2023
Q1 | $2.19K | Hold |
132
| – | – | ﹤0.01% | 1676 |
|
|
2022
Q4 | $2.46K | Hold |
132
| – | – | ﹤0.01% | 1608 |
|
|
2022
Q3 | $2K | Buy |
+132
| New | +$2K | ﹤0.01% | 1517 |
|